Enter to open, tab to navigate, enter to select
Kite Pharma, Inc. follow-on equity offering underwriting agreement of March 2, 2017
| March 02, 2017 • Underwriting Agreements • $356,250,000 |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.